Bill > S3469

This bill, the BIOSECURE Act of 2025, prohibits executive agencies from procuring or contracting with entities that use biotechnology equipment or services from "biotechnology companies of concern," which are defined as entities involved in biotechnology that are subject to the control of a foreign adversary or are identified by the Department of Defense as Chinese military companies. The bill aims to prevent foreign adversaries from acquiring sensitive American multiomic data, which includes genomics, epigenomics, transcriptomics, proteomics, and metabolomics, through biotechnology products and services. It outlines specific effective dates for these prohibitions, allows for waivers in certain national security or overseas healthcare service situations, and includes exceptions for intelligence activities and responses to public health emergencies. The Office of Management and Budget (OMB) is tasked with publishing a list of these "biotechnology companies of concern" based on recommendations from various government agencies, and the Federal Acquisition Regulation will be updated to implement these requirements. The bill also mandates reports on national security risks posed by foreign adversary acquisition of American multiomic data and intelligence on nefarious activities by biotechnology companies.

Military Affairs and Security

https://www.congress.gov/bill/119th-congress/senate-bill/3469/all-info